I dont know if you have looked at ahz but for both a short term and long term play I think it has some promise. just been through the last cr hopefully. share price depressed due to that and as uptake of their heart patch has been slower than initially anticipated but seems to be getting traction now as the gold standard. st I see 12c . over two year an easy Disallowed.
that's ignoring the vaccination stuff which could be a wild card.
and once the heart market is saturated, product can be used for other purposes abdominal and now dural repairs.
